← Back to Search

Behavioral Activation Therapy for Depression After Respiratory Failure (BEHAB Trial)

N/A
Recruiting
Led By Ann M Parker, MD
Research Sponsored by Johns Hopkins University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
At least mild depressive symptoms (score ≥2 on PHQ-2 scale)
Acute respiratory failure managed in the ICU > 24hrs with specific ventilation or oxygenation criteria
Timeline
Screening 3 weeks
Treatment Varies
Follow Up end of intervention (12 weeks)
Awards & highlights

BEHAB Trial Summary

This trial looks at a new therapy to help people who have survived respiratory failure and are struggling with depression and physical problems.

Who is the study for?
This trial is for adults over 18 who were living at home before ICU admission, experienced acute respiratory failure requiring intensive care for more than 24 hours, and have mild depressive symptoms. Excluded are those with long ICU stays, substance abuse or psychosis, severe prior disability, non-English speakers, homelessness or living far from the study site.Check my eligibility
What is being tested?
The study tests a combined therapy approach delivered through phone calls and home visits to treat depression and improve physical function in patients who've had serious respiratory issues requiring life support.See study design
What are the potential side effects?
Since this is a behavioral intervention focusing on mental health and physical rehabilitation rather than medication, side effects may include emotional discomfort during therapy sessions but are generally expected to be minimal.

BEHAB Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I experience mild depression symptoms.
Select...
I was in the ICU for over 24 hours for severe breathing problems needing special breathing support.
Select...
I am 18 years old or older.

BEHAB Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~end of intervention (12 weeks)
This trial's timeline: 3 weeks for screening, Varies for treatment, and end of intervention (12 weeks) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Feasibility measure
Feasibility measure per participant
Feasibility measure/Assess loss to follow-up
+1 more
Secondary outcome measures
Activity Measure for Post-Acute Care Computer Adaptive Test (AMPAC-CAT)
Behavioral Activation for Depression SCALE (BAS)
Brief Coping with Problems Experienced (Brief COPE)
+10 more

BEHAB Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Behavioral Activation - RehabilitationExperimental Treatment1 Intervention
Behavioral Activation - Rehabilitation
Group II: Usual Care ControlActive Control1 Intervention
Usual Care Control

Find a Location

Who is running the clinical trial?

Johns Hopkins UniversityLead Sponsor
2,273 Previous Clinical Trials
14,840,352 Total Patients Enrolled
57 Trials studying Depression
29,561 Patients Enrolled for Depression
National Heart, Lung, and Blood Institute (NHLBI)NIH
3,847 Previous Clinical Trials
47,818,572 Total Patients Enrolled
42 Trials studying Depression
68,460 Patients Enrolled for Depression
Ann M Parker, MDPrincipal InvestigatorJohns Hopkins University

Media Library

Behavioral Activation - Rehabilitation Clinical Trial Eligibility Overview. Trial Name: NCT03431493 — N/A
Depression Research Study Groups: Behavioral Activation - Rehabilitation, Usual Care Control
Depression Clinical Trial 2023: Behavioral Activation - Rehabilitation Highlights & Side Effects. Trial Name: NCT03431493 — N/A
Behavioral Activation - Rehabilitation 2023 Treatment Timeline for Medical Study. Trial Name: NCT03431493 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there currently any openings in this research project?

"As per the data hosted on clinicaltrials.gov, this medical trial is currently enlisting participants and has done so since March 2nd 2018 with its last edit occurring June 8th 2022."

Answered by AI

What goals is this medical research project hoping to achieve?

"The principal metric of the clinical trial, which will be assessed over a 12-week timeframe, is feasibility. Additional measurements include Connor-Davidson Resilience Scale (CD RISC), Behavioral Activation for Depression SCALE (BAS) and Number of phone attempts needed by the OT to reach the participant for each session as an indicator of adherence. The CD RISC comprises 25 items with 5 points per item - higher scores implying greater resilience - that yields a total score from 0 to 100. BAS consists of 25 items graded on 7 levels ranging from 0=not at all to 6=completely; it has 4 subscales: Activ"

Answered by AI

What is the aggregate amount of participants in this medical experiment?

"Affirmative, the clinical trial database confirms that this medical research is actively recruiting. This project was first advertised on March 2nd 2018 and had its last update June 8th 2022. 54 test subjects are needed for the study at a single location."

Answered by AI

Are participants aged 50 and under eligible for this medical experiment?

"This research necessitates that applicants be aged 18 to 100. There are 215 studies which cater exclusively to younger patients and an additional 1067 trials available for those past their prime years."

Answered by AI

Who qualifies as an eligible participant in this trial?

"To participate in this medical trial, applicants must have completed rehabilitation and be between 18 - 100 years old. The desired recruitment goal is 54 individuals."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Behavioral Activation-Rehabilitation to Improve Depressive Symptoms & Physical Function After Acute Respiratory Failure
2018. "Behavioral Activation-Rehabilitation to Improve Depressive Symptoms & Physical Function After Acute Respiratory Failure". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03431493.
All > Depression Baltimore > Treatment Resistant Depression
~0 spots leftby Jun 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top